Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Thumbnail

HHS provides $112 million in funding for cardiovascular disease

Seven regional cooperatives representing nearly 5,000 primary care clinicians in 12 states received a total of $112 million from the federal government to help prevent cardiovascular disease in their patients.

Cadillac tax for high-cost health plans concerns CFOs

CFOs are concerned with the "Cadillac tax" companies will have to pay starting in 2018 for offering high-cost health insurance plans.

Cyber attacks contribute to $6B in healthcare system costs

Computer hackers are increasingly targeting doctors and hospitals and are costing the U.S. healthcare system $6 billion. In 2014, 88.4 million people had their health records breached, nearly twice as many as in 2010.

Cardiac drug sales: Who’s on top & who’s slipping

AstraZeneca led the pack of pharmaceutical companies for revenue from cardiovascular drugs in 2014, according to a PMLive analysis. But of the top 10 companies, only Bayer and Takeda posted growth in sales that year. Here are figures for the leading companies.

Thumbnail

How to avoid being approved by the FDA but shunned by Medicare

The FDA and Medicare have different priorities. Getting the twain to meet sometimes takes a third party to show what is safe and effective can also be a value, too.  

Thumbnail

Most costs tied to index PCI, not 30-day hospitalizations

Efforts to reduce healthcare costs by targeting 30-day readmissions after PCI may be misguided. An analysis of Veterans Affairs (VA) hospitals attributed the majority of costs to the index procedure.

Thumbnail

Report finds healthcare billing, payment systems concern consumers

More than 40 percent people in fair or poor health found their medical bills were unaffordable and more than 25 percent said the bills were inaccurate and difficult to understand. The results of the PwC Health Research Institute survey were released on May 7.

Amarin sues FDA over off-label use discussions with physicians

Amarin Pharma sued the FDA on May 7 and declared it had the constitutional right to discuss off-label use of drugs with doctors, the New York Times reports.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.